首页 > 最新文献

Indian Journal of Medical Microbiology最新文献

英文 中文
Trends of drug resistance in M. tuberculosis in a reference laboratory in Central India: Forging ahead towards TB elimination 印度中部参考实验室结核杆菌的耐药性趋势:向消灭结核病迈进。
IF 1.4 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-14 DOI: 10.1016/j.ijmmb.2024.100701
Prabha Desikan , Nikita Panwalkar , Aseem Rangnekar , Zeba Khan , Ram Prakash Punde , Arun Kumar Sharma , Ragini Kushwaha , Chinnaiyan Ponnuraja , Sridhar Anand

Purpose

The National Tuberculosis Elimination Programme (NTEP) of the Government of India has strived to control tuberculosis (TB) in the country through various interventions. Understanding the trends of resistance patterns may provide insights into the effectiveness of TB control activities in the country.

Methods

A total of 31,144 clinical samples were received from 2013 to 2022 from presumptive drug-resistant TB patients. All the specimens were decontaminated and subjected to the line probe assay for detection of resistance to rifampicin and isoniazid. Mycobacterium tuberculosis (MTB) was detected in 28,814 samples. Autoregressive integrated moving average model (ARIMA) was fitted to assess the trend over time.

Results

A decreasing trend in multi-drug resistant TB from 19 % in 2013 to 4 % in 2022 was seen. A decreasing trend in rifampicin monoresistance from 11.2 % in 2013 to 1.5 % in 2022 was seen, though there was an increase in resistance in 2017. No significant decreasing trends were seen in the proportion of isoniazid monoresistance from 8.3 % in 2013 to 7 % in 2022.

Conclusion

The findings are encouraging, and to a considerable extent, affirm that India is well on track with regard to the goal of TB elimination.

目的:印度政府的国家消除结核病计划(NTEP)一直在努力通过各种干预措施控制该国的结核病(TB)。了解耐药性模式的趋势有助于深入了解该国结核病控制活动的有效性:从 2013 年到 2022 年,共收到 31,144 份临床样本,这些样本来自推定耐药的肺结核患者。所有样本都经过净化,并采用线探针检测法检测对利福平和异烟肼的耐药性。在 28,814 份样本中检测到了结核分枝杆菌(MTB)。采用自回归综合移动平均模型(ARIMA)评估随时间变化的趋势:耐多药结核病呈下降趋势,从 2013 年的 19% 降至 2022 年的 4%。利福平单耐药率呈下降趋势,从2013年的11.2%降至2022年的1.5%,但2017年耐药率有所上升。异烟肼单耐药性的比例从2013年的8.3%下降到2022年的7%,但没有明显的下降趋势:研究结果令人鼓舞,在很大程度上证明印度在实现消除结核病的目标方面进展顺利。
{"title":"Trends of drug resistance in M. tuberculosis in a reference laboratory in Central India: Forging ahead towards TB elimination","authors":"Prabha Desikan ,&nbsp;Nikita Panwalkar ,&nbsp;Aseem Rangnekar ,&nbsp;Zeba Khan ,&nbsp;Ram Prakash Punde ,&nbsp;Arun Kumar Sharma ,&nbsp;Ragini Kushwaha ,&nbsp;Chinnaiyan Ponnuraja ,&nbsp;Sridhar Anand","doi":"10.1016/j.ijmmb.2024.100701","DOIUrl":"10.1016/j.ijmmb.2024.100701","url":null,"abstract":"<div><h3>Purpose</h3><p>The National Tuberculosis Elimination Programme (NTEP) of the Government of India has strived to control tuberculosis (TB) in the country through various interventions. Understanding the trends of resistance patterns may provide insights into the effectiveness of TB control activities in the country.</p></div><div><h3>Methods</h3><p>A total of 31,144 clinical samples were received from 2013 to 2022 from presumptive drug-resistant TB patients. All the specimens were decontaminated and subjected to the line probe assay for detection of resistance to rifampicin and isoniazid. <em>Mycobacterium tuberculosis</em> (MTB) was detected in 28,814 samples. Autoregressive integrated moving average model (ARIMA) was fitted to assess the trend over time.</p></div><div><h3>Results</h3><p>A decreasing trend in multi-drug resistant TB from 19 % in 2013 to 4 % in 2022 was seen. A decreasing trend in rifampicin monoresistance from 11.2 % in 2013 to 1.5 % in 2022 was seen, though there was an increase in resistance in 2017. No significant decreasing trends were seen in the proportion of isoniazid monoresistance from 8.3 % in 2013 to 7 % in 2022.</p></div><div><h3>Conclusion</h3><p>The findings are encouraging, and to a considerable extent, affirm that India is well on track with regard to the goal of TB elimination.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100701"},"PeriodicalIF":1.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141971024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent pyogenic brain abscess in immunocompetent patient by Bacteroides fragilis: A silent cause of concern 由脆弱拟杆菌引起的免疫功能正常患者的复发性化脓性脑脓肿:令人担忧的隐患
IF 1.4 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-14 DOI: 10.1016/j.ijmmb.2024.100702
Sonu Kumari Agrawal , Tanu Sagar , P Sarat Chandra , Rama Chaudhry

Anaerobic bacteria are rare but important cause of otogenic brain abscess. Improved patient management techniques and early clinical and laboratory diagnosis of otogenic infections are necessary to reduce the risk of intracranial complications. Here we present a case of recurrent pyogenic brain abscess caused by Bacteroides fragilis secondary to otitis media.

厌氧菌是耳源性脑脓肿的罕见但重要的病因。要降低颅内并发症的风险,就必须改进患者管理技术,及早进行耳源性感染的临床和实验室诊断。在此,我们介绍一例由脆弱拟杆菌继发中耳炎引起的复发性化脓性脑脓肿病例。
{"title":"Recurrent pyogenic brain abscess in immunocompetent patient by Bacteroides fragilis: A silent cause of concern","authors":"Sonu Kumari Agrawal ,&nbsp;Tanu Sagar ,&nbsp;P Sarat Chandra ,&nbsp;Rama Chaudhry","doi":"10.1016/j.ijmmb.2024.100702","DOIUrl":"10.1016/j.ijmmb.2024.100702","url":null,"abstract":"<div><p>Anaerobic bacteria are rare but important cause of otogenic brain abscess. Improved patient management techniques and early clinical and laboratory diagnosis of otogenic infections are necessary to reduce the risk of intracranial complications. Here we present a case of recurrent pyogenic brain abscess caused by <em>Bacteroides fragilis</em> secondary to otitis media.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100702"},"PeriodicalIF":1.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden of drug-resistant tuberculosis by the GeneXpert MTB/RIF assay and its clinico-epidemiological aspects at a tertiary care hospital in West Bengal 西孟加拉邦一家三级甲等医院采用 GeneXpert MTB/RIF 检测法检测耐药结核病的负担及其临床流行病学方面的问题。
IF 1.4 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-14 DOI: 10.1016/j.ijmmb.2024.100703
Nupur Pal , Raja Ray , Somenath Kundu , Avijit Hazra , Singdha Sau , Suhita Sur , Shreya Saha , Wasim Mallick

Multidrug -resistant tuberculosis (MDRTB) is a serious threat to mankind. India has the highest number of MDRTB cases, although majority remain undiagnosed due to inadequate diagnostic infrastructure, leading to increased community transmission and mortality. This one-year observational retrospective study highlighted the effectiveness of the National Tuberculosis Elimination Program (NTEP) for prompt detection of drug-resistant TB by GeneXpert MTB/RIF assay and revealed its associated clinico-epidemiological factors. The overall detection rates of MTB and RRTB were 20.70 % and 20.86 % respectively. The pediatric population had 7.69 % rifampicin resistance, and HIV was strongly associated with the development of TB and RRTB (P < 0.01).

耐多药结核病(MDRTB)是对人类的严重威胁。印度是耐多药结核病例最多的国家,但由于诊断基础设施不足,大多数病例仍未得到诊断,导致社区传播和死亡率上升。这项为期一年的观察性回顾研究强调了国家消除结核病计划(NTEP)通过 GeneXpert MTB/RIF 检测法及时发现耐药结核病的有效性,并揭示了与之相关的临床流行病学因素。MTB 和 RRTB 的总体检出率分别为 20.70% 和 20.86%。儿科人群的利福平耐药率为 7.69%,艾滋病毒与结核病和 RRTB 的发生密切相关(P<0.05)。
{"title":"Burden of drug-resistant tuberculosis by the GeneXpert MTB/RIF assay and its clinico-epidemiological aspects at a tertiary care hospital in West Bengal","authors":"Nupur Pal ,&nbsp;Raja Ray ,&nbsp;Somenath Kundu ,&nbsp;Avijit Hazra ,&nbsp;Singdha Sau ,&nbsp;Suhita Sur ,&nbsp;Shreya Saha ,&nbsp;Wasim Mallick","doi":"10.1016/j.ijmmb.2024.100703","DOIUrl":"10.1016/j.ijmmb.2024.100703","url":null,"abstract":"<div><p>Multidrug -resistant tuberculosis (MDRTB) is a serious threat to mankind. India has the highest number of MDRTB cases, although majority remain undiagnosed due to inadequate diagnostic infrastructure, leading to increased community transmission and mortality. This one-year observational retrospective study highlighted the effectiveness of the National Tuberculosis Elimination Program (NTEP) for prompt detection of drug-resistant TB by GeneXpert MTB/RIF assay and revealed its associated clinico-epidemiological factors. The overall detection rates of MTB and RRTB were 20.70 % and 20.86 % respectively. The pediatric population had 7.69 % rifampicin resistance, and HIV was strongly associated with the development of TB and RRTB (P &lt; 0.01).</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100703"},"PeriodicalIF":1.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141916524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergy testing of ceftazidime-avibactam and aztreonam combination by two different methods 采用两种不同方法对头孢唑肟-阿维菌素和阿奇霉素复方制剂进行协同作用试验。
IF 1.4 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-14 DOI: 10.1016/j.ijmmb.2024.100705
Ekadashi Rajni, Kriti Goyal, Kanika R. Bairwa
{"title":"Synergy testing of ceftazidime-avibactam and aztreonam combination by two different methods","authors":"Ekadashi Rajni,&nbsp;Kriti Goyal,&nbsp;Kanika R. Bairwa","doi":"10.1016/j.ijmmb.2024.100705","DOIUrl":"10.1016/j.ijmmb.2024.100705","url":null,"abstract":"","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100705"},"PeriodicalIF":1.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of dried blood spots in the detection of coronavirus disease 2019 (COVID-19): A systematic review 使用干血斑检测 2019 年冠状病毒病 (COVID-19):系统综述。
IF 1.4 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-13 DOI: 10.1016/j.ijmmb.2024.100700
Jannie Nikolai M. Alquero , Patrizia Marie S. Estanislao , Svethlana Marie M. Hermino , Ranna Duben M. Manding , Joshua Euchie D. Robles , Christene Mae A. Canillo , Ourlad Alzeus G. Tantengco

Introduction

COVID-19 disease continues to be a global health concern. The current protocol for detecting SARS-CoV-2 requires healthcare professionals to draw blood from patients. Recent studies showed that dried blood spot (DBS) is a valuable sampling procedure that can collect a low blood volume without the need for the presence of medical practitioners. This study synthesized the available literature on using DBS as a blood collection tool to diagnose COVID-19 disease.

Materials and methods

A comprehensive search utilizing OVID, CINAHL, and Scopus databases was done from inception to March 2023. Five reviewers collected, extracted and organized the study data.

Results

This systematic review included 57 articles. DBS was commonly prepared by finger pricking. Most studies showed more favorable results and longer sample stability (more than 1080 days) with lower storage temperature conditions for the DBS. DBS samples were mostly used for serological assays for COVID-19 disease detection. ELISA was the most used detection method (43.66 %). Diagnostic performance of laboratory tests for COVID-19 using DBS sample showed high sensitivity of up to 100 % for immunoassay tests and 100 % specificity in agglutination, PCR, and DELFIA assays.

Conclusion

DBS sampling coupled with serological testing can be an alternative method for collecting blood and detecting COVID-19 disease. These tests using DBS samples showed excellent diagnostic performance across various geographic locations and demographics.

导言:COVID-19 疾病仍然是全球关注的健康问题。目前检测 SARS-CoV-2 的方案要求医护人员从患者身上抽血。最近的研究表明,干血斑(DBS)是一种有价值的采样方法,它可以采集少量血液,而不需要医护人员在场。本研究综述了使用干血斑作为采血工具诊断 COVID-19 疾病的现有文献:从开始到 2023 年 3 月,利用 OVID、CINAHL 和 Scopus 数据库进行了全面检索。五位审稿人收集、提取并整理了研究数据:本系统性综述共纳入 57 篇文章。DBS 通常采用手指刺穿法进行准备。大多数研究表明,在较低的储存温度条件下,DBS 的效果更佳,样本稳定性更长(超过 1080 天)。DBS 样本大多用于 COVID-19 疾病的血清学检测。ELISA 是使用最多的检测方法(43.66%)。使用 DBS 样本进行 COVID-19 实验室检测的诊断性能显示,免疫测定的灵敏度高达 100%,凝集、PCR 和 DELFIA 检测的特异性也达到 100%:结论:DBS 抽样与血清学检测相结合,可作为采集血液和检测 COVID-19 疾病的替代方法。这些使用 DBS 样本进行的检测在不同的地理位置和人口统计中都显示出了卓越的诊断性能。
{"title":"Use of dried blood spots in the detection of coronavirus disease 2019 (COVID-19): A systematic review","authors":"Jannie Nikolai M. Alquero ,&nbsp;Patrizia Marie S. Estanislao ,&nbsp;Svethlana Marie M. Hermino ,&nbsp;Ranna Duben M. Manding ,&nbsp;Joshua Euchie D. Robles ,&nbsp;Christene Mae A. Canillo ,&nbsp;Ourlad Alzeus G. Tantengco","doi":"10.1016/j.ijmmb.2024.100700","DOIUrl":"10.1016/j.ijmmb.2024.100700","url":null,"abstract":"<div><h3>Introduction</h3><p>COVID-19 disease continues to be a global health concern. The current protocol for detecting SARS-CoV-2 requires healthcare professionals to draw blood from patients. Recent studies showed that dried blood spot (DBS) is a valuable sampling procedure that can collect a low blood volume without the need for the presence of medical practitioners. This study synthesized the available literature on using DBS as a blood collection tool to diagnose COVID-19 disease.</p></div><div><h3>Materials and methods</h3><p>A comprehensive search utilizing OVID, CINAHL, and Scopus databases was done from inception to March 2023. Five reviewers collected, extracted and organized the study data.</p></div><div><h3>Results</h3><p>This systematic review included 57 articles. DBS was commonly prepared by finger pricking. Most studies showed more favorable results and longer sample stability (more than 1080 days) with lower storage temperature conditions for the DBS. DBS samples were mostly used for serological assays for COVID-19 disease detection. ELISA was the most used detection method (43.66 %). Diagnostic performance of laboratory tests for COVID-19 using DBS sample showed high sensitivity of up to 100 % for immunoassay tests and 100 % specificity in agglutination, PCR, and DELFIA assays.</p></div><div><h3>Conclusion</h3><p>DBS sampling coupled with serological testing can be an alternative method for collecting blood and detecting COVID-19 disease. These tests using DBS samples showed excellent diagnostic performance across various geographic locations and demographics.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100700"},"PeriodicalIF":1.4,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Epstein-Barr virus (EBV) with nasopharyngeal carcinoma: Experience from a North Indian tertiary care hospital Epstein-Barr 病毒 (EBV) 与鼻咽癌的关系:北印度一家三级医院的经验。
IF 1.4 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-09 DOI: 10.1016/j.ijmmb.2024.100699
Debasish Biswal , Megha Brijwal , Aashish Choudhary , Aanchal Kakkar , Raja Pramanik , Alok Thakar , Lalit Dar

Introduction

Nasopharyngeal carcinoma (NPC), arising from nasopharyngeal epithelium is caused by Epstein-Barr virus (EBV). It is common in South China, South East Asia and North East India. The aim and objectives of this study were to determine the prevalence of EBV in formalin-fixed paraffin-embedded (FFPE) tissue sections of clinically suspected NPC patients, correlate the results of polymerase chain reaction (PCR) with histopathology findings, and to determine the utility of tissue EBV DNA as a diagnostic bio-marker.

Materials and methods

31 FFPE tissue samples were collected from clinically suspected NPC patients from April 2018–December 2019. Histopathological diagnosis was done by examination of Hematoxylin and Eosin stained slides. Presence of EBV was detected by EBNA-1 PCR. IHC was performed using EBV Latent Membrane Protein 1.

Results

Of the 31 clinically suspected NPC cases, 15 (48.4 %) were histopathological confirmed NPC. Of these15, 13 (86.6 %) were non-keratinising undifferentiated NPC, and one each were keratinising NPC and non-keratinising differentiated NPC respectively.

EBV EBNA1 PCR was positive in 35.5 % (11/31) of clinically suspected NPC cases. Of the 11 PCR positive cases, 9 (81.8 %) were histopathological confirmed NPC.

Of the 31 clinically suspected NPC cases, IHC was indicated in 23 biopsies. Of which, 12 (52.2 %) were positive for LMP1 in the abnormal cells. Of the 12 IHC positive samples, 10 were NPC cases.

Conclusion

EBV DNA as an indicator towards NPC among clinically suspected cases had a sensitivity of 60 % and specificity of 87.5 %. In this study, addition of EBV DNA detection by PCR from FFPE tissue sections could confirm EBV association in 20 % of cases where it was not detected by EBV LMP1 IHC, thus helped in increasing the detection of EBV positivity in NPC cases. Early diagnosis of NPC will improve the cure rate and hence reduce the morbidity and mortality rates.

简介鼻咽癌(NPC)是由爱泼斯坦-巴氏病毒(EBV)引起的鼻咽上皮癌。鼻咽癌常见于华南、东南亚和印度东北部。本研究的目的和目标是确定EBV在临床疑似鼻咽癌患者福尔马林固定石蜡包埋(FFPE)组织切片中的流行率,将聚合酶链反应(PCR)结果与组织病理学结果相关联,并确定组织EBV DNA作为诊断生物标志物的效用。材料和方法:从2018年4月至2019年12月,从临床疑似鼻咽癌患者处收集了31份FFPE组织样本。通过检查苏木精和伊红染色的切片进行组织病理学诊断。通过 EBNA-1 PCR 检测是否存在 EBV。采用 EBV 潜伏膜蛋白 1 进行 IHC 检测:在 31 例临床疑似鼻咽癌病例中,15 例(48.4%)经组织病理学确诊为鼻咽癌。其中13例(86.6%)为非角化性未分化鼻咽癌,角化性鼻咽癌和非角化性分化鼻咽癌各1例。在临床疑似鼻咽癌病例中,35.5%(11/31)的病例EBV EBNA1 PCR呈阳性。在11例PCR阳性病例中,9例(81.8%)经组织病理学确诊为鼻咽癌。在 31 例临床疑似鼻咽癌病例中,23 例活检结果显示 IHC 呈阳性。其中 12 例(52.2%)异常细胞中的 LMP1 呈阳性。在 12 份 IHC 阳性样本中,有 10 例为鼻咽癌病例:结论:将 EBV DNA 作为临床疑似病例的鼻咽癌指标,灵敏度为 60%,特异性为 87.5%。在这项研究中,通过对 FFPE 组织切片进行 PCR 检测,可在 20% 的病例中证实 EBV LMP1 IHC 检测不到的 EBV 相关性,从而有助于提高鼻咽癌病例中 EBV 阳性的检测率。鼻咽癌的早期诊断将提高治愈率,从而降低发病率和死亡率。
{"title":"Association of Epstein-Barr virus (EBV) with nasopharyngeal carcinoma: Experience from a North Indian tertiary care hospital","authors":"Debasish Biswal ,&nbsp;Megha Brijwal ,&nbsp;Aashish Choudhary ,&nbsp;Aanchal Kakkar ,&nbsp;Raja Pramanik ,&nbsp;Alok Thakar ,&nbsp;Lalit Dar","doi":"10.1016/j.ijmmb.2024.100699","DOIUrl":"10.1016/j.ijmmb.2024.100699","url":null,"abstract":"<div><h3>Introduction</h3><p>Nasopharyngeal carcinoma (NPC), arising from nasopharyngeal epithelium is caused by Epstein-Barr virus (EBV). It is common in South China, South East Asia and North East India. The aim and objectives of this study were to determine the prevalence of EBV in formalin-fixed paraffin-embedded (FFPE) tissue sections of clinically suspected NPC patients, correlate the results of polymerase chain reaction (PCR) with histopathology findings, and to determine the utility of tissue EBV DNA as a diagnostic bio-marker.</p></div><div><h3>Materials and methods</h3><p>31 FFPE tissue samples were collected from clinically suspected NPC patients from April 2018–December 2019. Histopathological diagnosis was done by examination of Hematoxylin and Eosin stained slides. Presence of EBV was detected by EBNA-1 PCR. IHC was performed using EBV Latent Membrane Protein 1.</p></div><div><h3>Results</h3><p>Of the 31 clinically suspected NPC cases, 15 (48.4 %) were histopathological confirmed NPC. Of these15, 13 (86.6 %) were non-keratinising undifferentiated NPC, and one each were keratinising NPC and non-keratinising differentiated NPC respectively.</p><p>EBV EBNA1 PCR was positive in 35.5 % (11/31) of clinically suspected NPC cases. Of the 11 PCR positive cases, 9 (81.8 %) were histopathological confirmed NPC.</p><p>Of the 31 clinically suspected NPC cases, IHC was indicated in 23 biopsies. Of which, 12 (52.2 %) were positive for LMP1 in the abnormal cells. Of the 12 IHC positive samples, 10 were NPC cases.</p></div><div><h3>Conclusion</h3><p>EBV DNA as an indicator towards NPC among clinically suspected cases had a sensitivity of 60 % and specificity of 87.5 %. In this study, addition of EBV DNA detection by PCR from FFPE tissue sections could confirm EBV association in 20 % of cases where it was not detected by EBV LMP1 IHC, thus helped in increasing the detection of EBV positivity in NPC cases. Early diagnosis of NPC will improve the cure rate and hence reduce the morbidity and mortality rates.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100699"},"PeriodicalIF":1.4,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing HIV care: Insights from CD4 count, viral load, and demographic factors in a tertiary care centre of South Gujarat "优化艾滋病护理:从南古吉拉特邦一家三级护理中心的 CD4 细胞计数、病毒载量和人口因素中获得的启示"。
IF 1.4 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-07 DOI: 10.1016/j.ijmmb.2024.100696
Komal Kanani, Sangita Rajdev, Summaiya Mullan

Purpose

Despite advancements in prevention, diagnosis, and treatment, HIV/AIDS remains a critical health concern, particularly in India. This study contributes valuable insights into HIV management strategies. This prospective and retrospective longitudinal observational study aimed to analyze the trends in CD4 cell count and viral load suppression among adult People Living with HIV (PLHIV) undergoing antiretroviral therapy (ART) and evaluate the influence of demographic factors and ART adherence on these parameters at the ART Centre of New Civil Hospital, Surat, India.

Materials & methods

Adult PLHIV registered and initiated on ART between June 2017 and May 2018 at ART-NCH, Surat with Continuous follow-up until 2023 were included in the study. Data was collected and Statistical analysis was performed using Microsoft Excel and SPSS software. Other factors were evaluated for their influence on treatment outcomes.

Results

A longitudinally analyzed data from 365 adult PLHIV receiving ART with continuous follow-up until 2023 revealed significant trends, with CD4 counts increasing from 425 (1st month) to 612.67 (24th month), indicating improving immune function. Individuals on first-line ART regimens had significantly higher odds (OR: 3.5, 95 % CI: 1.1–11.3) of achieving CD4 counts ≥350 compared to those on second-line regimens. Adherence to treatment (OR: 1.98, 95 % CI: 1.1–3.4) also increased the odds of attaining CD4 counts ≥350. Viral load suppression was achieved in 353 out of 365 participants.

Conclusion

This study highlights the need for tailored interventions to optimize immune recovery and viral load suppression among PLHIV. Recommendations include targeted intervention to improve long-term health outcomes.

目的:尽管在预防、诊断和治疗方面取得了进步,但艾滋病毒/艾滋病仍然是一个严重的健康问题,尤其是在印度。本研究为艾滋病管理策略提供了宝贵的见解。这项前瞻性和回顾性纵向观察研究旨在分析接受抗逆转录病毒疗法(ART)的成年艾滋病病毒感染者(PLHIV)的 CD4 细胞计数和病毒载量抑制趋势,并评估人口统计学因素和坚持抗逆转录病毒疗法对印度苏拉特新民事医院 ART 中心这些参数的影响 材料与方法:研究纳入了 2017 年 6 月至 2018 年 5 月期间在苏拉特 ART-NCH 登记并开始接受抗逆转录病毒疗法并持续随访至 2023 年的成年艾滋病病毒感染者。使用 Microsoft Excel 和 SPSS 软件收集数据并进行统计分析。评估了其他因素对治疗结果的影响 结果:对接受抗逆转录病毒疗法的 365 名成年 PLHIV 的数据进行了纵向分析。持续跟踪至 2023 年的数据显示,CD4 细胞计数从 425(第 1 个月)上升至 612.67(第 24 个月),表明免疫功能正在改善。与采用二线疗法的患者相比,采用一线抗逆转录病毒疗法的患者达到 CD4 细胞计数≥350 的几率(OR:3.5,95% CI:1.1-11.3)明显更高。坚持治疗(OR:1.98,95% CI:1.1-3.4)也增加了CD4计数≥350的几率。365名参与者中有353人实现了病毒载量抑制 结论:这项研究强调,有必要采取有针对性的干预措施,以优化艾滋病毒感染者的免疫恢复和病毒载量抑制。建议包括采取有针对性的干预措施,以改善长期健康状况。
{"title":"Optimizing HIV care: Insights from CD4 count, viral load, and demographic factors in a tertiary care centre of South Gujarat","authors":"Komal Kanani,&nbsp;Sangita Rajdev,&nbsp;Summaiya Mullan","doi":"10.1016/j.ijmmb.2024.100696","DOIUrl":"10.1016/j.ijmmb.2024.100696","url":null,"abstract":"<div><h3>Purpose</h3><p>Despite advancements in prevention, diagnosis, and treatment, HIV/AIDS remains a critical health concern, particularly in India. This study contributes valuable insights into HIV management strategies. This prospective and retrospective longitudinal observational study aimed to analyze the trends in CD4 cell count and viral load suppression among adult People Living with HIV (PLHIV) undergoing antiretroviral therapy (ART) and evaluate the influence of demographic factors and ART adherence on these parameters at the ART Centre of New Civil Hospital, Surat, India.</p></div><div><h3>Materials &amp; methods</h3><p>Adult PLHIV registered and initiated on ART between June 2017 and May 2018 at ART-NCH, Surat with Continuous follow-up until 2023 were included in the study. Data was collected and Statistical analysis was performed using Microsoft Excel and SPSS software. Other factors were evaluated for their influence on treatment outcomes.</p></div><div><h3>Results</h3><p>A longitudinally analyzed data from 365 adult PLHIV receiving ART with continuous follow-up until 2023 revealed significant trends, with CD4 counts increasing from 425 (1st month) to 612.67 (24th month), indicating improving immune function. Individuals on first-line ART regimens had significantly higher odds (OR: 3.5, 95 % CI: 1.1–11.3) of achieving CD4 counts ≥350 compared to those on second-line regimens. Adherence to treatment (OR: 1.98, 95 % CI: 1.1–3.4) also increased the odds of attaining CD4 counts ≥350. Viral load suppression was achieved in 353 out of 365 participants.</p></div><div><h3>Conclusion</h3><p>This study highlights the need for tailored interventions to optimize immune recovery and viral load suppression among PLHIV. Recommendations include targeted intervention to improve long-term health outcomes.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100696"},"PeriodicalIF":1.4,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141878646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MicroRNA profiles in Zika virus infection: Insights from diverse sources 寨卡病毒感染的微RNA图谱:从不同来源获得的启示。
IF 1.4 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-05 DOI: 10.1016/j.ijmmb.2024.100697
Mohammad Javad Mousavi , Nasir Arefinia , Mohammad Azarsa , Taraneh Hoseinnezhad , Emad Behboudi

Background

Zika virus (ZIKV) stands as one of the most significant reemerging viral pathogens, linked to neurological diseases such as meningoencephalitis and congenital microcephaly. Today there are no effective therapies for treating ZIKV-infected patients. MiRNAs play a critical role in regulating cellular signaling and physiological conditions, and alterations in their profiles can bear great significance in disease progression.

Objectives

Despite significant progress in understanding the interaction between the ZIKV and its host since the outbreak, a more comprehensive understanding on these interactions is imperative. This review aims to summarize the studies in the field and shed light on the intricate relationship between ZIKV and its host at the molecular level.

Content

We found that in ZIKV-infected humans, over-expression of miR-431–5p and miR-30e-5p plays a crucial role in innate immune responses and contributes to neurological damage. Additionally, in ZIKA-infected mice, we observed upregulated expression of all the targets of miR-124–3p including CCL2, IL7, IRF1, and SBNO2. Notably, other targets of this miRNA include TLR6, TNF, STAT3, and NF-kB also exhibited upregulation in the central nervous system (CNS) of infected mice. Conversely, miR-654–3p levels were reduced, correlating with the upregulation of its predicted targets including FLT3LG, LITAF, CD69, and TLR2. In the case of insects, aae-miR-286a/b-3p was predicted to target all ZIKV genotypes. This specific miRNA is typically found in ovaries and can be transferred to embryos. In conclusion, our findings suggest that host microRNAs and ZIKV-encoded microRNAs hold promise as potential targets for the diagnosis of ZIKV infections and may even serve as a therapeutic approach for managing this infectious disease.

背景:寨卡病毒(ZIKV)是重新出现的最重要病毒病原体之一,与脑膜脑炎和先天性小头畸形等神经系统疾病有关。目前还没有治疗 ZIKV 感染者的有效疗法。MiRNA在调节细胞信号传导和生理状况方面发挥着关键作用,其谱系的改变对疾病的进展具有重要意义:尽管自疫情爆发以来,人们在了解 ZIKV 与宿主之间的相互作用方面取得了重大进展,但当务之急是更全面地了解这些相互作用。本综述旨在总结该领域的研究,从分子水平阐明 ZIKV 与宿主之间错综复杂的关系:我们发现,在ZIKV感染的人类中,miR-431-5p和miR-30e-5p的过度表达在先天性免疫反应中起着至关重要的作用,并导致神经损伤。此外,在 ZIKA 感染的小鼠中,我们观察到 miR-124-3p 的所有靶标(包括 CCL2、IL7、IRF1 和 SBNO2)都表达上调。值得注意的是,该 miRNA 的其他靶标包括 TLR6、TNF、STAT3 和 NF-kB 也在感染小鼠的中枢神经系统(CNS)中表现出上调。相反,miR-654-3p 水平降低,这与其预测靶标(包括 FLT3LG、LITAF、CD69 和 TLR2)的上调有关。在昆虫中,aae-miR-286a/b-3p 被预测为所有 ZIKV 基因型的靶标。这种特定的 miRNA 通常存在于卵巢中,并可转移到胚胎中。总之,我们的研究结果表明,宿主微RNA和ZIKV编码的微RNA有望成为诊断ZIKV感染的潜在靶标,甚至可能成为控制这种传染病的治疗方法。
{"title":"MicroRNA profiles in Zika virus infection: Insights from diverse sources","authors":"Mohammad Javad Mousavi ,&nbsp;Nasir Arefinia ,&nbsp;Mohammad Azarsa ,&nbsp;Taraneh Hoseinnezhad ,&nbsp;Emad Behboudi","doi":"10.1016/j.ijmmb.2024.100697","DOIUrl":"10.1016/j.ijmmb.2024.100697","url":null,"abstract":"<div><h3>Background</h3><p>Zika virus (ZIKV) stands as one of the most significant reemerging viral pathogens, linked to neurological diseases such as meningoencephalitis and congenital microcephaly. Today there are no effective therapies for treating ZIKV-infected patients. MiRNAs play a critical role in regulating cellular signaling and physiological conditions, and alterations in their profiles can bear great significance in disease progression.</p></div><div><h3>Objectives</h3><p>Despite significant progress in understanding the interaction between the ZIKV and its host since the outbreak, a more comprehensive understanding on these interactions is imperative. This review aims to summarize the studies in the field and shed light on the intricate relationship between ZIKV and its host at the molecular level.</p></div><div><h3>Content</h3><p>We found that in ZIKV-infected humans, over-expression of miR-431–5p and miR-30e-5p plays a crucial role in innate immune responses and contributes to neurological damage. Additionally, in ZIKA-infected mice, we observed upregulated expression of all the targets of miR-124–3p including CCL2, IL7, IRF1, and SBNO2. Notably, other targets of this miRNA include TLR6, TNF, STAT3, and NF-kB also exhibited upregulation in the central nervous system (CNS) of infected mice. Conversely, miR-654–3p levels were reduced, correlating with the upregulation of its predicted targets including FLT3LG, LITAF, CD69, and TLR2. In the case of insects, aae-miR-286a/b-3p was predicted to target all ZIKV genotypes. This specific miRNA is typically found in ovaries and can be transferred to embryos. In conclusion, our findings suggest that host microRNAs and ZIKV-encoded microRNAs hold promise as potential targets for the diagnosis of ZIKV infections and may even serve as a therapeutic approach for managing this infectious disease.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100697"},"PeriodicalIF":1.4,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pestalotiopsis, a rare cause of mycetoma; A case report Pestalotiopsis,一种罕见的霉菌瘤病因;病例报告。
IF 1.4 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-05 DOI: 10.1016/j.ijmmb.2024.100690
Archana Keche , Satyaki Ganguly , Swati Gajbhiye , Girish Patil

Pestalotiopsis is an appendage-bearing, well-known plant pathogen, and very few species are associated with human infections. To best of our knowledge, this is first report of Pestalotiopsis spp. isolated from mycetoma patient in India. A 66-year-old male farmer, having a history of twig prick, presented with a swollen foot and multiple discharging sinuses. 10 % KOH mount of tissue and grain showed fragmented fungal elements. White to pale honey-colored colonies with undulated edges and shiny black granules grew on potato dextrose agar. Characteristic fusiform, 5-celled conidia with 2–3 apical appendages seen on LPCB mount. Patient was treated with systemic Itraconazole successfully.

Pestalotiopsis是一种带有附属物的著名植物病原体,与人类感染有关的种类很少。据我们所知,这是第一份从印度霉菌瘤患者体内分离出 Pestalotiopsis 菌属的报告。一名 66 岁的男性农民曾被树枝刺伤,出现脚部肿胀和多处窦道分泌物。组织和谷物的 10% KOH 切片显示出碎裂的真菌成分。在马铃薯葡萄糖琼脂上长出了白色至淡蜂蜜色的菌落,边缘呈波状,并有发亮的黑色颗粒。在 LPCB 装片上可以看到特征性的纺锤形 5 室分生孢子,顶端有 2-3 个附属物。患者接受伊曲康唑系统治疗后获得成功。
{"title":"Pestalotiopsis, a rare cause of mycetoma; A case report","authors":"Archana Keche ,&nbsp;Satyaki Ganguly ,&nbsp;Swati Gajbhiye ,&nbsp;Girish Patil","doi":"10.1016/j.ijmmb.2024.100690","DOIUrl":"10.1016/j.ijmmb.2024.100690","url":null,"abstract":"<div><p><em>Pestalotiopsis</em> is an appendage-bearing, well-known plant pathogen, and very few species are associated with human infections. To best of our knowledge, this is first report of <em>Pestalotiopsis</em> spp. isolated from mycetoma patient in India. A 66-year-old male farmer, having a history of twig prick, presented with a swollen foot and multiple discharging sinuses. 10 % KOH mount of tissue and grain showed fragmented fungal elements. White to pale honey-colored colonies with undulated edges and shiny black granules grew on potato dextrose agar. Characteristic fusiform, 5-celled conidia with 2–3 apical appendages seen on LPCB mount. Patient was treated with systemic Itraconazole successfully.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100690"},"PeriodicalIF":1.4,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological analysis of leptospirosis, dengue, and Co-infection rates among febrile illness cases in Dakshina Kannada, Karnataka 卡纳塔克邦达克希纳卡纳达区发热病例中钩端螺旋体病、登革热和合并感染率的流行病学分析。
IF 1.4 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-03 DOI: 10.1016/j.ijmmb.2024.100698
R.K. Veena , K. Vinod Kumar , M. Swathi , P.P. Bokade , A. Pal , S. SowjanyaKumari , Y.P. Arun , S. Devaraj , K. Jagadeesha , M.R. Padma , M. Jayashankar , H.B. ChethanKumar , B.R. Shome , B.R. Gulati , V. Balamurugan

Introduction

Leptospirosis and dengue are two significant public health concerns in tropical and subtropical regions, often resulting in severe forms of disease and fatality. This study addresses the pressing public health issues of leptospirosis and dengue in the Dakshina Kannada district of Karnataka, India. Both diseases pose significant health risks and are relatively understudied in this region, making it essential to investigate their prevalence and clinical presentations for targeted healthcare planning.

Aim

The primary aim is to determine the frequency of leptospirosis and dengue among febrile illness cases to understand the epidemiological patterns and assess co-infection rates in Dakshina Kannada.

Method

Between 2020 and 2021, serum samples suspected of leptospirosis were tested using IgM ELISA (n = 1629) and the Microscopic Agglutination Test (MAT) (n = 92) for leptospirosis, while dengue was tested using NS1Ag and IgM antibodies ELISA (n = 1415). Data were collected through medical records and patient interviews. Seasonal trends, gender, and age distributions were analyzed.

Result

The study found a significant prevalence of leptospirosis (21 %) and dengue (10 %) among febrile illness cases in the study area, with a 1.3 % co-infection rate. Clinically, fever was common to both diseases, but leptospirosis also frequently exhibited symptoms such as abdominal pain, myalgia, and jaundice. MAT screening revealed a predominance of anti-leptospiral antibodies against the Djasiman, Pyrogenes, Hurstbridge, Hebdomadis, and Grippotyphosa serogroups in Dakshina Kannada.

Conclusion

The study highlights the urgent need for focused public health interventions, improved diagnostic tools, and targeted epidemiological studies to manage these diseases. The findings underscore the necessity of enhancing diagnostic capabilities and public health awareness, particularly considering the significant health risks posed by leptospirosis and dengue in the region.

导言:钩端螺旋体病和登革热是热带和亚热带地区的两大公共卫生问题,通常会导致严重的疾病和死亡。本研究探讨了印度卡纳塔克邦达克希纳卡纳达地区钩端螺旋体病和登革热这两个紧迫的公共卫生问题。目的:主要目的是确定发热病例中钩端螺旋体病和登革热的发病频率,以了解流行病学模式并评估达克希纳卡纳达的合并感染率:2020年至2021年期间,使用IgM ELISA(1 629人)和显微镜下凝集试验(MAT)(92人)检测疑似钩端螺旋体病和登革热的血清样本,使用NS1Ag和IgM抗体ELISA(1 415人)检测登革热。数据通过病历和患者访谈收集。对季节趋势、性别和年龄分布进行了分析:研究发现,在研究地区的发热病例中,钩端螺旋体病(21%)和登革热(10%)的发病率很高,合并感染率为 1.3%。临床上,这两种疾病都有发热,但钩端螺旋体病还经常表现出腹痛、肌痛和黄疸等症状。MAT 筛查显示,在达克希纳卡纳达,抗钩端螺旋体抗体主要针对 Djasiman、Pyrogenes、Hurstbridge、Hebdomadis 和 Grippotyphosa 血清群:这项研究强调,迫切需要采取重点突出的公共卫生干预措施、改进诊断工具和开展有针对性的流行病学研究,以控制这些疾病。特别是考虑到钩端螺旋体病和登革热在该地区造成的重大健康风险,研究结果强调了提高诊断能力和公共卫生意识的必要性。
{"title":"Epidemiological analysis of leptospirosis, dengue, and Co-infection rates among febrile illness cases in Dakshina Kannada, Karnataka","authors":"R.K. Veena ,&nbsp;K. Vinod Kumar ,&nbsp;M. Swathi ,&nbsp;P.P. Bokade ,&nbsp;A. Pal ,&nbsp;S. SowjanyaKumari ,&nbsp;Y.P. Arun ,&nbsp;S. Devaraj ,&nbsp;K. Jagadeesha ,&nbsp;M.R. Padma ,&nbsp;M. Jayashankar ,&nbsp;H.B. ChethanKumar ,&nbsp;B.R. Shome ,&nbsp;B.R. Gulati ,&nbsp;V. Balamurugan","doi":"10.1016/j.ijmmb.2024.100698","DOIUrl":"10.1016/j.ijmmb.2024.100698","url":null,"abstract":"<div><h3>Introduction</h3><p>Leptospirosis and dengue are two significant public health concerns in tropical and subtropical regions, often resulting in severe forms of disease and fatality. This study addresses the pressing public health issues of leptospirosis and dengue in the Dakshina Kannada district of Karnataka, India. Both diseases pose significant health risks and are relatively understudied in this region, making it essential to investigate their prevalence and clinical presentations for targeted healthcare planning.</p></div><div><h3>Aim</h3><p>The primary aim is to determine the frequency of leptospirosis and dengue among febrile illness cases to understand the epidemiological patterns and assess co-infection rates in Dakshina Kannada.</p></div><div><h3>Method</h3><p>Between 2020 and 2021, serum samples suspected of leptospirosis were tested using IgM ELISA (n = 1629) and the Microscopic Agglutination Test (MAT) (n = 92) for leptospirosis, while dengue was tested using NS1Ag and IgM antibodies ELISA (n = 1415). Data were collected through medical records and patient interviews. Seasonal trends, gender, and age distributions were analyzed.</p></div><div><h3>Result</h3><p>The study found a significant prevalence of leptospirosis (21 %) and dengue (10 %) among febrile illness cases in the study area, with a 1.3 % co-infection rate. Clinically, fever was common to both diseases, but leptospirosis also frequently exhibited symptoms such as abdominal pain, myalgia, and jaundice. MAT screening revealed a predominance of anti-leptospiral antibodies against the Djasiman, Pyrogenes, Hurstbridge, Hebdomadis, and Grippotyphosa serogroups in Dakshina Kannada.</p></div><div><h3>Conclusion</h3><p>The study highlights the urgent need for focused public health interventions, improved diagnostic tools, and targeted epidemiological studies to manage these diseases. The findings underscore the necessity of enhancing diagnostic capabilities and public health awareness, particularly considering the significant health risks posed by leptospirosis and dengue in the region.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100698"},"PeriodicalIF":1.4,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141878648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Medical Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1